Dr. Gunther von Hagens 'HUMAN SAGA' Project Presents Sexuality and Reproduction in New Exhibit, The Cycle of Life.
BERLIN, May 5 /PRNewswire/ -- Anatomist, Dr. Gunther von
Hagens, creator of the BODY WORLDS exhibitions, who set out three years ago to present the human saga in its entirety, introduced the latest volume in his "HUMAN SAGA" project this week.
Gunther Von Hagens' BODY WORLDS and KORPERWELTEN - Not Affiliated With Paris Copycat Display
HEIDELBERG, Germany, April 22 /PRNewswire/ -- The Institute for Plastination in Heidelberg, Germany and its Scientific Director, anatomist Dr. Gunther von
Hagens - creators of the world renowned anatomical exhibitions: BODY WORLDS and KORPERWELTEN - categorically state that their exhibitions a...
Anatomist Dr. Gunther von Hagens, Pioneer of Anatomical Exhibitions Not Affiliated With Copycat Display in Paris
HEIDELBERG, Germany, Feb. 23 /PRNewswire/ -- Anatomist Dr. Gunther von
Hagens - creator of the world renowned BODY WORLDS anatomical exhibitions that bear his name - issued a clarification to French media and public in response to recent media reports that confused a cadaver display announced in...
Cancer Researcher Dan Von Hoff, M.D. Advocates for "Context of Vulnerability," A Powerful New Paradigm for Targeted Drug Development
Renowned cancer researcher Dr. Daniel Von
Hoff and his team at TGen are fervent believers in a new approach to developing novel therapies for patients with pancreatic cancer. They are guided by a rationale dubbed the "context of vulnerability." Dr. Von
Hoff provides case studies and ex...
Renowned Cancer Researcher Dan Von Hoff, M.D. Advocates for 'The Lost Opportunity in Phase I Oncology Trials'
Renowned oncology researcher Dr. Daniel Von
Hoff, a member of President Bush's National Cancer Advisory Board, provides an in-depth look at the "lost opportunity" in phase I oncology clinical trials. While most biotechnology companies use the phase I trial to evaluate a drug's toxicity...
Dr. Daniel Von Hoff Discusses "The Complete Phase Ib," A Clinical Trial Design Offering Faster Drug Development, Economies of Scale and Improved Therapeutic Benefit
Renowned oncology researcher Dr. Daniel Von
Hoff, a member of President Bush's National Cancer Advisory Board, provides an in-depth look at "The Complete Phase Ib," an oncology clinical trial design that creates rapid accrual rates, substantial economies of scale, significant time ...
Gunther von Hagens' BODY WORLDS Exhibitions Welcome Specimens From World's First Living Body Donor for Plastination
LOS ANGELES, June 10 /PRNewswire/ -- For 35 year old Mark Rohner of
London, Ohio, the amputation of his right leg due to bone cancer reads like
the plot point in a medical drama. During the operation in 2006, the saw
the chief surgeon was using to detach Rohner's limb from his knee, broke
Gunther Von Hagens' BODY WORLDS Exhibitions Mark 25th Million Visitor Milestone
DENVER, April 29 /PRNewswire/ -- Gunther von
Hagens' BODY WORLDS, the
traveling anatomical exhibitions of donor bodies welcomes its 25th million
visitor this week. Though it will not be known if the distinction will go
to a visitor entering the turnstile at BODY WORLDS in Los Angeles, or if
Agito Networks Wins the 2008 VON Magazine Innovator Award for Enterprise Mobility VON
Magazine Recognizes the Need for Location-Based Mobile Convergence
Solutions for Enterprises by Naming Agito Networks an Innovator Award Winner
SUNNYVALE, Calif., March 13 /PRNewswire/ -- Agito Networks, Inc., a
company pioneering new technology in enter...
Anatomist Dr. Gunther von Hagens Clarifies: Plastinates Not For Sale
HEIDELBERG, Germany, Feb. 5 /PRNewswire/ -- During a lengthy interview
with a reporter from a tabloid in Guben, Germany on Feb 4. 2008 anatomist,
Dr. Gunther von
Hagens explained his views on anatomy, the poor access to
medical knowledge by lay people, and his own professional evolution from
Bionic Ear Restores Hearing to Von Hippel-Lindau Disease Patients
Scientists have for the first time shown that a bionic ear may help restore hearing in patients with von
Researchers at Georgetown University Medical Center and the National Institutes of Health (NIH) say that their work offers new hope for patients with the rare dis...
FDA Approves New Product to Treat Von Willebrand Disease
The U.S. Food and Drug Administration (FDA) today announced the approval of Antihemophilic Factor/von Willebrand Factor Complex (Human), Alphanate. //The product is approved for patients undergoing surgery or invasive procedures with von
Willebrand disease (vWD) in whom the hormone desmopressin is ...
2009 American Association of Pharmaceutical Scientists Annual Meeting and Exposition
Progress in the expedition and accuracy in getting more targeted and efficient medications to patients.
Keynote speakers include:
Eschenbach, Former Commissioner, U.S. Food and Drug Administration
Trisha Meili, motivational speaker often described as the "Central Park Jogger" ...
Addario Lung Cancer Medical Institute Announces Diagnostic Screening and Clinical Research Collaborations With Response Genetics, Inc.
...h its C ollaborative A dvanced S tage T issue L ung Canc e r (CASTLE) Network in the fall of 2009.
Media Relations Contact:
For more information, contact Mr. Steven Young at email@example.com or
FDA Warnings on Mercury Tooth Fillings Expected Today: New Regulation Result of Lawsuit Settled Last Year
...sensitive populations, of its use.
The ruling results from a lawsuit settled last year by the plaintiffs in the case of Moms Against Mercury v. von
Eschenbach. The settlement required FDA to withdraw claims of amalgam's safety from its web site and reclassify its use by July 28, 2009.
ACC Responds to Study Published in Pediatrics About Phthalate and IV Tubing
ARLINGTON, Va., July 27 /PRNewswire-USNewswire/ -- The American Chemistry Council (ACC) today responded to the article in Pediatrics: H. von
Rettberg, T. Hannman, U. Subotic, J. Brade, T. Schaible, K. L. Waag, S. Loff, Use of Di(2-Ethylhexyl)Phthalate-Containing Infusion Systems Increases t...
Culture May Help Raise Breast Cancer Death Rate for American Indians
...ight the significance of cultural beliefs and attitudes when designing effective cancer-risk reduction and cancer-control interventions," said Marlene von
Freiderichs-Fitzwater, the assistant adjunct professor of hematology and oncology, and director of the UC Davis Outreach, Research and Education Progr...
HPV, Other Risk Factors Tied to Oral Cancer: New Web Site Offers Awareness, Early Detection Information
... Included in the staggering amount of people affected by oral cancer are well-known celebrities such as Rod Stewart , Aaron Spelling , Diane von
Furstenburg and Peter Tork , drummer for the 1960s hit band, The Monkees.
Despite the deadly nature of this disease, the American public...
BODY WORLDS Anatomical Exhibitions of Donor Bodies Receives 28 Millionth Visitor.
... LOS ANGELES, July 21 /PRNewswire / -- Gunther von
Hagens' BODY WORLDS , the original anatomical exh...ns--curated 'chapters' from anatomist, Dr. Gunther von
Hagens' "HUMAN SAGA" project--have broken attendan...d philosophical reflection and insights," said Dr. von
The exhibitions are made possible...
New global subsidy for malaria medicines must ensure quality of care
...ust remain focused on quality patient care if it is to succeed, argues Tido von
Schoen-Angerer and colleagues in this week's open access journal PLoS Medi...es (ACTs) for malaria, and fears about growing resistance to the drugs. Dr. von
Schoen-Angerer and colleagues cite a recent household survey across 18 Afri...
PR Whiz Belinda Foster Launches Michael Jackson's Nurse, Cherilyn Lee, on World Media Campaign
...NN, including Anderson Cooper, Larry King, and Nancy Grace; CBS Early Show; Insider; LA TIMES; NY DAILY NEWS; PEOPLE Magazine; and FOX NEWS WITH GRETA von
SUSTEREN, to name a few. A day after her introduction to America with this information, authorities discovered DIPRIVAN at the Jackson home. As a moth...
Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal(R) Vet, a New Chemotherapeutic Agent for Dogs
...ts in more than 130 countries.
Abbott's news releases and other information are available on the company's Web site at www.abbott.com .
Euler H, Akerlund-Denneberg N, Rivera P, Bergvall K, Kessler M, Rowe A, Willmann M, Persson G, Kastengren Froberg G, Westberg S and Kristianson K. Eff...
Pioneer of Digital Place-Based Media Joins World's Leading Blood Pressure and Health Kiosk Manufacturer
...re monitors and health testing stations, names Lon von
Hurwitz Executive Vice President of Business Devel..., 2009 -- Lifeclinic International has named Lon von
Hurwitz Executive Vice President of Business Development. von
Hurwitz, previously President of Sales for Health ...
Case Western Reserve University Receives $5M From Third Frontier Commission for the Center for Stem Cell & Regenerative Medicine
...companied by a subset of eight new pilot projects determined through review by CSCRM oversight committees.
Paul Tesar (CWRU), Horst von
Recum (CWRU) and Jeremy Rich (CC) will establish a Pluripotent Stem Cell Facility within CWRU and CC which will be the first of its kind in the State ...
e-Zassi.com(TM) Specialized Software Systems for the Medical Device Industry Named by LifeScience Alley(R) As Preferred Provider
...orations and technologies from around the world using the e-Zassi's proprietary Device Network Attributes (DNA) powered logic.
According to Peter von
Dyck, e-Zassi.com founder and CEO, "The relationship with LifeScience Alley and its members underscores the importance of multi-disciplinary collabora...
PharmaSURVEYOR's Advanced Drug Safety Service Connects to Microsoft HealthVault
... of services connected by HealthVault," said Erick von
Schweber, Executive Co-Chair of PharmaSURVEYOR. "F...solve any problems; PharmaSURVEYOR does!" said Mr. von
Schweber. "PharmaSURVEYOR enables the HealthVault ...econciliation. For more information, contact Linda von
Schweber at firstname.lastname@example.org " target="_n...
Researchers Detect Blood-Clotting Mechanism
...lied to the highly-sensitive A2 domain of the blood-clotting protein called von
Willebrand factor (VWF), which acts as a "force sensor," the researchers ex... lead to new treatments for injuries or bleeding disorders, such as type 2A von
Willebrand disease, the researchers noted.
Experts reach consensus on diagnosis and treatment of bleeding disorders in women
... gynecology and hematology reached consensus, recommendations were made.
Willebrand Disease (VWD) is the most common inherited bleeding disorder. VWD results from a deficiency in, or a dysfunction of, von
Willebrand factor (VWF), a protein necessary for normal platelet adhesion a...
Immune-Based Lymphoma Treatment Shows Promise
... first prospective randomized trial of this combination," said Dr. Margaret von
Mehren, a medical oncologist with Fox Chase Cancer Center in Philadelphia. ... thoracic oncology program, Fox Chase Cancer Center, Philadelphia; Margaret von
Mehren, M.D., medical oncologist, Fox Chase Cancer Center, Philadelphia; Ma...
ASGE and ASGE Foundation hold Crystal Awards Dinner as part of Digestive Disease Week
...The awards are underwritten by a grant from Cook Medical.
Sun-Young Lee, MD, Konkuk University School of Medicine, Seoul, Republic of Korea
Renteln, MD, Klinikum Ludwigsburg, Ludwigsburg, Germany
Andres Sanchez Yague, MD, Hospital Costa del Sol, Marbella, Spain
PAREXEL International to Present at Goldman Sachs Annual Global Healthcare Conference and the Jefferies Annual Healthcare Conference
... Corporation (Nasdaq: PRXL ) announced today it will be presenting at the Goldman Sachs 30th Annual Global Healthcare Conference in New York. Josef von
Rickenbach, Chairman & Chief Executive Officer will be making a formal presentation on PAREXEL at 3:10 p.m. EDT on Tuesday, June 9, 2009.
Intercell to Webcast Research & Development Day on Thursday, June 4, 2009
...ll AG, Reinhard Kandera, Chief Financial Officer of Intercell AG, Alexander von
Gabain, Chief Scientific Officer of Intercell AG and Gregory M. Glenn, Chie...mas Lingelbach, COO Intercell AG
-- Scientific Update
Gabain, CSO Intercell AG
-- Financial Update & Outlook
Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research
...Treatment of Pancreatic Cancer" / Leaders: Craig B. Thompson, M.D., Director, Abramson Cancer Center at the University of Pennsylvania, and Daniel D. von
Hoff, M.D., Senior Investigator and Physician in Chief at the Translational Research Genomics Institute (TGen).
The projects address some of th...
San Diego Psychiatrist Scott Irwin Honored With National Recognition
...aordinary achievement for someone so early in his career," said Dr. Charles von
Gunten, M.D., Ph.D., Provost of The Institute for Palliative Medicine. "Sco...is little money to go around for new investigators in our field," notes Dr. von
Gunten. "In obtaining research funding, the first grant is always the most ...
$18 million awarded to TGen and University of Pennsylvania for pancreatic cancer research
...Up to Cancer (SU2C) announced today.
Dr. Daniel von
Hoff, TGen's Physician-In-Chief, and Dr. Craig B. ...eam together to work towards this goal,'' said Dr. von
Hoff, who also is Chief Scientific Officer for TGe...ther debilitating diseases.
About Dr. Daniel von
In addition to his positions at TGen and ...
New Program Offsets Risks of 'Do-It-Yourself' Gestational Surrogacy
... when financing is tight or unavailable in the current economy," said Robin von
Halle, president of ARR.
"But the surrogacy relationship can be a tou...ed parents' desire to take control of this process is understandable," said von
Halle. "But they are not likely to have the knowledge or the contacts to ma...
Cylene to Announce New Data on Its First-in-Class Oral CK2 Inhibitor Against Cancer at BIO Conference
...tic agents with its two proprietary product discovery platforms, using novel chemistry and biology capabilities. The company was co-founded by Daniel von
Hoff, MD, one of the world's leading oncology clinical investigators. In addition to the CK2 inhibitor CX-4945, Cylene's Nucleolus Targeting Technolo...
$1.5 million awarded for palliative care research to improve care of seriously ill patients
...disease and prognosis and resources to assist the clinician with the conversation.
Northwestern University, Feinberg School of Medicine Jamie H. von
Roenn, M.D., a professor of medicine at Northwestern University, Feinberg School of Medicine, is a medical oncologist and expert in palliative medicin...
InDex Pharmaceuticals AB Engages PharmaVentures to Facilitate the Licensing of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early
Svante Rasmuson, CEO
Phone: +46 (0)8 50 88 47 31
Mobile: +46 (0)708 63 93 31
Phone: +46 (0)8 50 88 47 32
Mobile: +46 (0)708 93 33 75
Hospira Highlights Five Years of Progress and Future Opportunities at Its 2009 Annual Meeting of Shareholders
...ng directors: Christopher B. Begley, Barbara L. Bowles, Roger H. Hale and John C. Staley, all Class II directors whose terms expire in 2012; and Heino von
Prondzynski, a Class III director whose term expires in 2010;
ratified the appointment of Deloitte & Touche LLP as Hospira's auditors fo...